Opportunity Information: Apply for PA 07 316

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Research on Clinical Decision Making in Life Threatening Illness (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361 Nursing Research 93.395 Cancer Treatment Research.
  • This funding opportunity was created on Apr 2, 2009 and posted on Jan 19, 2007.
  • Applicants must submit their applications by May 7, 2009 Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: Private institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) Independent school districts Public and State controlled institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Special district governments.
  • Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
Apply for PA 07 316

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH funding opportunity "Research on Clinical Decision Making in Life Threatening Illness (R21)" (Funding Opportunity Number PA-07-316) is designed to support exploratory studies on how people make clinical and health-related decisions when they are facing conditions that can become fatal relatively quickly if untreated, but that may be manageable as chronic diseases or even curable when caught early. The opportunity is sponsored by the National Institute of Nursing Research (NINR) and the National Cancer Institute (NCI), reflecting an interest in both nursing-centered and cancer-centered perspectives on decision processes across the full course of serious illness. The central goal is to stimulate research that clarifies what drives decision making, how decisions change over time, and how individuals weigh risks, benefits, uncertainty, personal values, and the practical realities of treatment and care.

The announcement emphasizes that "life threatening illness" includes conditions that have a high likelihood of leading to death in a short period without treatment, while also acknowledging that modern medicine can transform some of these illnesses into longer-term conditions or cure them if addressed early. The examples provided illustrate this range: HIV infection can become a chronic condition for many people with effective therapy, while cancers such as breast cancer may be curable when detected and treated early. Because decision points arise throughout prevention, diagnosis, treatment, and end-of-life care, the opportunity is intentionally broad about where research can focus along the illness trajectory.

A key feature of the FOA is its interest in decision making from the earliest stages through the final stages of life. That includes decisions about adopting preventive behaviors, seeking screening or testing, and evaluating whether to participate in research. It also includes choices made after diagnosis, such as selecting among treatment options, deciding between active treatment and watchful waiting (the example given is early-stage prostate cancer), enrolling in therapeutic clinical trials, and making end-of-life care decisions. In practice, this means projects could examine how patients and families interpret information, how clinicians communicate risk and prognosis, how cultural or spiritual beliefs influence preferences, how prior experiences shape choices, and how factors like health literacy, trust in the medical system, cost burdens, or access to care change what people decide and when.

This opportunity uses the NIH Exploratory/Developmental Research Grant (R21) mechanism, which is typically meant for early-stage, high-potential studies that generate preliminary data, develop measures or methods, or test innovative concepts that can lead to larger projects later. The FOA notes it runs in parallel with a companion announcement of identical scientific scope that uses the R01 mechanism (PA-07-062), which is generally more appropriate for mature, fully powered studies. In other words, PA-07-316 is aimed at investigators who want to explore emerging questions or build foundational evidence about decision processes in serious illness, potentially laying the groundwork for subsequent R01-level research.

In terms of funding parameters, the award ceiling listed is $200,000, and there is no cost sharing or matching requirement. The number of awards is not fixed; awards depend on congressional appropriations, NIH institute budgets, and the submission of enough high-quality applications. The opportunity is categorized as discretionary and uses the grant funding instrument, with activity areas spanning education and health. The CFDA numbers associated with the program are 93.361 (Nursing Research) and 93.395 (Cancer Treatment Research), which signals the cross-cutting relevance to nursing science and oncology-related decision making.

Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses and other for-profit entities), and a range of government bodies such as state governments, county governments, city or township governments, special district governments, and independent school districts. Native American tribal governments (federally recognized) and tribal organizations (including those not federally recognized) are also eligible, as are public housing authorities/Indian housing authorities. The announcement additionally specifies that foreign institutions may apply, eligible federal agencies may apply, and faith-based or community-based organizations are permitted applicants, which broadens the potential for community-engaged or internationally relevant work in decision making around life-threatening disease.

Administratively, the FOA was originally posted on January 19, 2007, with multiple receipt dates rather than a single deadline, and it reflects a closing date of May 7, 2009, with an archive date of June 7, 2009. Applicants were directed to the full announcement for the specific receipt schedule and detailed instructions, and NIH provided a contact route through the NIH Office of Extramural Research (OER) webmaster for access or linking problems. Overall, the opportunity is best understood as an NIH effort to encourage innovative, early-stage research that explains and improves the real-world decision making that patients and families must navigate when confronting illnesses where timing, uncertainty, and high stakes can profoundly shape outcomes and quality of life.

Frequently Asked Questions (FAQs)

What is the name of this NIH funding opportunity?

The opportunity is titled "Research on Clinical Decision Making in Life Threatening Illness (R21)."

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is PA-07-316.

What is the main purpose of PA-07-316?

Its purpose is to support exploratory studies on how people make clinical and health-related decisions when facing illnesses that can become fatal relatively quickly if untreated, but may be manageable as chronic diseases or even curable if caught early.

Which NIH institutes sponsor this FOA?

The FOA is sponsored by the National Institute of Nursing Research (NINR) and the National Cancer Institute (NCI).

Why are NINR and NCI both involved?

The joint sponsorship reflects interest in decision making from both nursing-centered and cancer-centered perspectives, and supports research on decision processes across the full course of serious illness.

What does the FOA mean by "life threatening illness"?

It refers to conditions with a high likelihood of leading to death in a short period without treatment, while recognizing that modern medicine can transform some of these illnesses into long-term conditions or cure them if addressed early.

What examples of life-threatening illness are mentioned?

The FOA notes that HIV infection can become a chronic condition for many people with effective therapy, and that some cancers (such as breast cancer) may be curable when detected and treated early.

What kinds of decision making does this FOA want to study?

The FOA emphasizes research that clarifies what drives decision making, how decisions change over time, and how individuals weigh risks, benefits, uncertainty, personal values, and practical realities of treatment and care.

Does the FOA limit research to a specific stage of illness?

No. It is intentionally broad and is interested in decision making from the earliest stages through the final stages of life, including prevention, screening/testing, diagnosis, treatment, and end-of-life care.

What are examples of early-stage decision points covered by this FOA?

Examples include decisions about adopting preventive behaviors, seeking screening or testing, and evaluating whether to participate in research.

What are examples of post-diagnosis decisions covered by this FOA?

Examples include selecting among treatment options, deciding between active treatment and watchful waiting (with early-stage prostate cancer given as an example), enrolling in therapeutic clinical trials, and making end-of-life care decisions.

What types of influences on decision making are highlighted?

The FOA notes that projects could examine how patients and families interpret information, how clinicians communicate risk and prognosis, how cultural or spiritual beliefs influence preferences, how prior experiences shape choices, and how health literacy, trust in the medical system, cost burdens, or access to care affect decisions and timing.

What grant mechanism does PA-07-316 use?

It uses the NIH Exploratory/Developmental Research Grant (R21) mechanism.

What is the R21 mechanism intended for in this FOA?

R21 is positioned as a way to support early-stage, high-potential studies that generate preliminary data, develop measures or methods, or test innovative concepts that can lead to larger projects later.

Is there a related FOA for more mature studies?

Yes. The announcement notes a companion FOA with identical scientific scope that uses the R01 mechanism: PA-07-062.

How is the R01 companion FOA different, according to the description provided?

The R01 mechanism is described as generally more appropriate for mature, fully powered studies, while PA-07-316 (R21) is aimed at exploratory and developmental work.

What is the award ceiling for this opportunity?

The award ceiling listed is $200,000.

Is cost sharing or matching required?

No. The FOA states there is no cost sharing or matching requirement.

How many awards will NIH make under this FOA?

The number of awards is not fixed. It depends on congressional appropriations, NIH institute budgets, and the submission of enough high-quality applications.

What type of funding instrument is used?

The opportunity uses the grant funding instrument.

How is this opportunity categorized?

It is categorized as discretionary.

What activity areas does this FOA fall under?

The activity areas are described as spanning education and health.

What CFDA numbers are associated with this program?

The CFDA numbers listed are 93.361 (Nursing Research) and 93.395 (Cancer Treatment Research).

What organizations are eligible to apply?

Eligibility is broad and includes public and private institutions of higher education; nonprofit organizations (both 501(c)(3) and non-501(c)(3)); for-profit organizations (including small businesses and other for-profit entities); and multiple levels of government, including state, county, city or township, special district governments, and independent school districts.

Are tribal entities eligible to apply?

Yes. Native American tribal governments (federally recognized) and tribal organizations (including those not federally recognized) are eligible.

Are public housing authorities eligible?

Yes. Public housing authorities/Indian housing authorities are listed as eligible applicants.

Can foreign institutions apply?

Yes. The announcement specifies that foreign institutions may apply.

Can federal agencies apply?

Yes. The announcement specifies that eligible federal agencies may apply.

Are faith-based or community-based organizations allowed to apply?

Yes. The FOA explicitly permits faith-based or community-based organizations as applicants.

When was this FOA originally posted?

It was originally posted on January 19, 2007.

Does this FOA have a single application deadline?

No. It used multiple receipt dates rather than a single deadline, and applicants were directed to the full announcement for the specific receipt schedule.

What are the listed closing and archive dates?

The FOA reflects a closing date of May 7, 2009, and an archive date of June 7, 2009.

Where were applicants directed for detailed instructions and receipt dates?

Applicants were directed to the full announcement for the detailed instructions and the specific receipt schedule.

Who is listed as a contact for access or linking problems?

NIH provided a contact route through the NIH Office of Extramural Research (OER) webmaster for access or linking problems.

What is the overall emphasis of this funding opportunity?

It emphasizes innovative, early-stage research that explains and improves real-world decision making by patients and families confronting serious illness, where timing, uncertainty, and high stakes can shape outcomes and quality of life.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Mental Health Consequences of Violence and Trauma (R03)

Previous opportunity: Neurobiology of Migraine (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 316

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 316) also looked into and applied for these:

Funding Opportunity
Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) NIDA (R03) Apply for PAS 07 327

Funding Number: PAS 07 327
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PAS 07 326

Funding Number: PAS 07 326
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PAS 07 324

Funding Number: PAS 07 324
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PAS 07 325

Funding Number: PAS 07 325
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Academic Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01) Apply for PAR 07 214

Funding Number: PAR 07 214
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NIDA Research Education Grants in Drug Abuse and Addiction (R25) Apply for PAR 07 221

Funding Number: PAR 07 221
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Neuroscience Research on Drug Abuse (R01) Apply for PA 07 226

Funding Number: PA 07 226
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Neuroscience Research on Drug Abuse (R21) Apply for PA 07 227

Funding Number: PA 07 227
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Neuroscience Research on Drug Abuse(R03) Apply for PA 07 228

Funding Number: PA 07 228
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Collaborative Clinical Trials in Drug Abuse (R01) Apply for PAR 07 232

Funding Number: PAR 07 232
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 07 329

Funding Number: PA 07 329
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 07 331

Funding Number: PA 07 331
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 07 330

Funding Number: PA 07 330
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R01) Apply for PA 07 333

Funding Number: PA 07 333
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R21) Apply for PA 07 334

Funding Number: PA 07 334
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Development of Animal Models and Related Biological Materials For Research (R21) Apply for PA 07 336

Funding Number: PA 07 336
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R01) Apply for PA 07 338

Funding Number: PA 07 338
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R03) Apply for PA 07 339

Funding Number: PA 07 339
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R21) Apply for PA 07 340

Funding Number: PA 07 340
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Developing And Improving Institutional Animal Resources (G20) Apply for PAR 07 342

Funding Number: PAR 07 342
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 316", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.